DBV Technologies has withdrawn its EU marketing authorization application (MAA) for Viaskin Peanut (Arachis hypogaea extract), an investigational patch for peanut allergy in children that was rejected for marketing in the US in 2020.
The company withdrew the MAA after learning from the European Medicines Agency that the trial data it used in the...